Macrophages are integral to most tissues. Foam cells, macrophages with lipid droplets (LDs) which are stores of triacylglycerols (TGs) and cholesterol esters (CEs), are found in various disease states 1 . LDs can act as energy stores since TG lipolysis releases fatty acids (FAs) for mitochondrial oxidation (FAO), a process that relies on long-chain FA conversion into acylcarnitines by the enzyme Cpt1a 2 . However, in macrophages, proinflammatory signals result in diminished FAO and increased TG synthesis with LD development 3,4 . We explored the significance of LDs in cells that do not utilize FAO. We show that macrophages stimulated with lipopolysaccharide (LPS) plus interferon-g (IFNg) accumulate TGs in LDs, and long-chain acylcarnitines. In these cells, inhibition of TG synthesis results in diminished LD development, and increased long chain acylcarnitine levels, suggesting that FA fate is balanced between TG and acylcarnitine synthesis. Nevertheless, TG-synthesis is required for inflammatory macrophage function, since its inhibition negatively affects production of proinflammatory IL-1b, IL-6 and PGE2, and phagocytic capacity, and protects against LPS-induced shock in vivo. Failure to make PGE2 is critical for this phenotype, since exogenous PGE2 reverses the anti-inflammatory effects of TG-synthesis inhibition. These findings place LDs in a position of central functional importance in inflammatory macrophages.
Inflammation has critical protective functions, but when unregulated can also cause disease, in which IL-1b and other proinflammatory cytokines are implicated 5 . Recent work has established a strong link between inflammatory activation signals and induced changes in macrophage metabolism that are essential for the cells to perform their subsequent functions 6 . Major components of this metabolic reprogramming include enhanced Warburg metabolism, associated with diminished oxidative phosphorylation (OXPHOS) and altered TCA cycle dynamics in which glucose carbon is redistributed via citrate/aconitate to the synthesis of fatty acids (FA) and itaconate 7 . Increased FA synthesis in inflammatory macrophages is associated with additional broad changes in lipid metabolism 8 , including the accumulation of TGs and CEs 3, 9 , which are stored within LDs. TG synthesis depends on the acyl-CoA:diacylglycerol acyltransferases 1 and/or 2 (DGAT1,2) 10 , which catalyze the covalent addition of a fatty acyl chain to diacylglycerol (DG) 10 . LDs are the core energy storage organelles of adipocytes, but develop in other cell types as well, where they can again act as energy stores for fueling cell intrinsic ATP production via mitochondrial FAO 2, 11 .
However, LDs are recognized to mediate additional functions including the sequestration of toxic lipids and the prevention of excessive endoplasmic reticulum (ER) stress, and as lipid donors for autophagosome formation 2, 12, 13 .
In vivo, LD-containing macrophages are most well recognized in atherosclerotic lesions and in tuberculosis 1, 14 . More recent work has highlighted the presence of foam cells in active multiple sclerosis, certain cancers, white adipose tissue during obesity, and in bronchoalveolar lavage from individuals suffering from vaping-related lung disease 1 . The ratio of TGs to CEs in LDs in different settings is likely to be important, and there is ongoing discussion regarding whether macrophages that contain CE-rich LDs are universally proinflammatory 15, 16 .
Inflammatory macrophages increase the commitment of resources to FA synthesis 7 .
Consistent with this, these cells accumulate LDs 3, 9, 4 but the function of LDs in this setting is unclear, especially since inflammatory macrophages do not use FAO 3, 4 . We began to address this by investigating the process and functional significance of TG synthesis in response to the strong proinflammatory stimulus provided by LPS plus IFNg (Fig. 1a ). We found that the expression of both Dgat1 and Dgat2, the enzymes responsible for synthesizing TGs from DGs, increased in inflammatory macrophages as part of a broader transcriptional signature of genes involved in TG synthesis and utilization ( Fig. 1a ), but that Dgat1 was most strongly expressed ( Fig. S1a ). As expected, TG and LD accumulation were also marks of inflammatory activation (Figs. 1b, c, d ). Consistent with their use for TG synthesis (Fig. 1a ), overall levels of free FAs and DGs were diminished in inflammatory compared to resting macrophages (Fig. 1e ). Lipidomics revealed broad, dynamic changes in lipids as a result of inflammatory activation, with the accumulation of phosphatidylcholines (PCs), phosphatidylinositols (PIs), phosphatidylehtanolamines (PEs), lysophosphotidylcholines (LPCs), sphingomyelins (SMs), CEs and hexosylceramides (HEXCERs) beginning as early as 2 h post activation ( Fig. S1b ). This was not the case in IL-4-stimulated alternatively activated macrophages ( Fig. S1b ), which actively fuel FAO by lipolysis and which, unlike inflammatory macrophages, do not contain visible LDs 4 .
Despite the fact that FAO and OXPHOS are inhibited during inflammatory activation 3, 17 , expression of Cpt1a, which encodes carnitine palmitoyltransferase 1a (Cpt1a), was increased in inflammatory macrophages ( Fig. S1c ). Cpt1a is an enzyme located in the outer mitochondrial membrane that converts long chain FA into acylcarnitines that can then be transported into the mitochondrial intermembrane space prior to subsequent transfer into the matrix for entry into FAO. We found that increased Cpt1a was associated with a significant drop in free carnitine correlated with the accumulation of long chain acylcarnitines (Figs. 1f, S1d). This was despite parallel increases in expression of Cpt2, which encodes the enzyme that catalyzes the removal of carnitine from aceylcarnitines ( Fig. S1c ). These changes did not correlate with utilization of FA in FAO, since while incorporation of 13 C from labeled palmitate into C16 acylcarnitine was increased in inflammatory vs. resting macrophages, its incorporation into the TCA cycle intermediate citrate was diminished ( Fig. 1g ). This is consistent with previous findings that FAO declines in inflammatory macrophages.
Furthermore, in inflammatory compared to resting macrophages 13 C from 13 C-labelled glycerol was preferentially incorporated into the TG precursor glycerol phosphate, rather than being used in glycolysis, where it is measurable as labeled 3-phosphoglycerate ( Fig. S1e ).
Taken together, our data support the view that inflammatory macrophages divert available resources towards the conversion of FAs to TGs which are stored in LDs, or to the synthesis of long chain acylcarnitines ( Fig. 1h ).
To ascertain the role of TGs in inflammatory macrophages, we used T863, a selective DGAT1 inhibitor (DGAT1i) 18 to suppress TG accumulation (Figs. 2a, b; S2a). This was accompanied by diminished LD accumulation ( Fig. 2c ), correlated with reduced staining with bodipy 493/503 ( Fig. 2d ), and diminished C16 bodipy uptake ( Fig. 2e ). DGATi also resulted in reduced levels of CEs and cardiolipins (CLs), and certain species of HEXCERs, PCs, PSs and SMs, although it had no effect on PIs and caused increases in LPCs ( Fig. S2a ). DGAT1i also caused the accumulation of substrate DGs in inflammatory macrophages (Figs. 2f; S2b), but free FA levels were unaffected ( Fig. S2c ), presumably because these were still being used to synthesize DGs. Suppression of DGAT1 using shRNA ( Fig. S2d ) resulted in effects that were similar to those mediated by DGAT1i, with diminished TG accumulation ( Fig. 2g) and staining with bodipy 493/503 ( Fig. 2h ). We next queried the effects of loss of DGAT1 function on inflammatory activation. We found that the failure to make TGs and thereby accumulate LDs in DGAT1i-treated or Dgat1-shRNA-transduced LPS/IFNg-stimulated cells was accompanied by a significant reduction in inflammatory capacity, as measured by IL-1b (Figs. 2i, j; S2e) and IL-6 production (Figs. 2k, l; S2f). Il1b and Il6 mRNAs were also diminished by DGAT1i (Fig. S2g ). These data are consistent with a previous report that DGATi diminished inflammatory cytokine production in an M. tuberculosis-infected human macrophage cell line 19 . Additionally, we observed marked reductions in mRNAs encoding the Macrophage Inflammatory Proteins 1a (Ccl3) and b (Ccl4), the inflammasome Nalp1 (Nlrp1b), and reductions in expression of additional genes involved in the inflammatory response including Ido1 and Il1a in inflammatory macrophages as a result of DGAT1 inhibition ( Fig. S2g ), attesting to the proinflammatory effects of TG synthesis. The reduction in Il1a expression is of interest since IL-1a was strongly implicated in the pathophysiology of atherosclerosis associated with foamy macrophage development in oleate-fed mice 20 .
Earlier work showed that interfering with LD dynamics through the inhibition of TG hydrolysis negatively impacted the ability of macrophages to engage in phagocytosis 21 . Here, we observed reduced phagocytic ability following loss of DGAT1 function (Figs. 2m, S2h).
We found that inhibiting DGAT1 also had significant effects on inflammation in vivo. T863treatment of mice with LPS-induced systemic inflammation significantly diminished disease severity, which was measured as the hypothermic response to i.p. LPS injection ( Fig. 2n ).
Mice that had received the drug were active and appeared unaffected by LPS injection at the Moreover, T863-treatment resulted in significantly decreased serum IL-1b ( Fig. 2q ) and IL-6 ( Fig. 2r ). Taken together, these results indicate that the synthesis of TGs and their storage in LDs supports inflammatory macrophage activation.
Macrophage activation driven by IFNg plus LPS is linked to increased aerobic glycolysis and the diversion of the TCA cycle intermediates citrate/aconitate to the production of itaconate 6, 7 . We reasoned that reduced inflammatory capacity associated with loss of DGAT1 function might be linked to alterations in one or more of these parameters. However, we found that LPS/IFNg-stimulated cells. We also assessed mitochondrial function. We found that inner membrane potential (a mark of the proton gradient across the inner membrane) ( Fig. 3e ) and mitochondrial mass ( Fig. 3f ) were equivalent or greater, respectively, in cells that lacked DGAT1 function, and that mitochondrial reactive oxygen species (ROS) were increased (Figs. 3g, S3c). Consistent with diminished respiration in inflammatory macrophages 17 , ultrastructural analyses revealed that mitochondrial cristae in these cells were looser than in resting cells 22, 23 , but this parameter was not obviously affected by DGAT1 inhibition (Fig. 3h; data not shown). As expected, LDs were evident in inflammatory macrophages to a greater extent than in resting macrophages (Fig. S3d ), and these organelles were less frequent in cells treated with DGAT1i ( Figs. 3h, S3d ).
In other cell types, DGAT1 inhibition has been associated with increased ROS and increased long chain acylcarnitine accumulation 24 . Similarly, we found increased long chain TGs are synthesized in the ER, which we have previously reported is significantly expanded in dendritic cells activated by LPS 25 . We found a similar effect in in macrophages following stimulation with LPS plus IFNg (Figs. 3j, S3f). Whereas in DCs, ER expansion was shown to require fatty acid synthesis, and to support increased cytokine production, here we found that despite causing diminished cytokine production, inhibition of TG synthesis resulted in an additional increase in ER (Figs. 3j, S3f). We speculate that this may reflect the accumulation of intermediates of the TG synthesis pathway in the ER.
As a means to understand underlying changes in inflammatory function we explored the transcriptional signature associated with loss of DGAT1 function. Inhibition of DGAT1 resulted in significant changes in expression of 285 genes ( Fig. S4a ). Amongst the six most significantly downregulated pathways within this set, three were linked to eicosanoids, with two specifically associated with the regulation of prostaglandin secretion (Fig. 4a ). PGE2 is produced by inflammatory macrophages, in which expression of both prostaglandin synthases Ptges1 and Ptges2 was elevated compared to in resting macrophages ( Fig. S4c ).
Previous work has localized PGE2 synthesis to LDs 26 , and postulated that eicosanoid production is a major function of these organelles in immune cells 27 . Moreover, recent findings have implicated autocrine effects of PGE2 in the production of IL-1b 28 . Given that loss of DGAT1 function resulted in loss of LDs (Figs. 2g, h), and of IL-1b production, we asked whether it affected PGE2 levels and thereby inflammatory function. We found that PGE2 production was significantly increased in response to inflammatory signals, and consistent with a role for TGs in PGE2 synthesis, suppressed by DGAT1 inhibition (Fig. 4b) ,
and that exogenous PGE2 increased pro IL-1b and IL-6 production by inflammatory macrophages in the presence of DGAT1i (Figs. 4c, d) or Dgat1-shRNA (Figs. S4d, e). There was also a proinflammatory effect of exogenous PGE2 in cells in which DGAT1 was functional (Figs. 4c, d; S4d, e), but the PGE2-induced fold increase in cytokine production was significantly greater in cells in which TG synthesis was inhibited (Figs. 4e, S4f). We found that the addition of exogenous PGE2 also reversed the decline in phagocytosiscompetent cells associated with loss of DGAT1 function (Fig. 4f ). Moreover, PGE2 increased the intrinsic phagocytic capacity of both control and Dgat1-shRNA-transduced inflammatory macrophages ( Fig. S4g ). Thus, our results indicate that inflammatory macrophages require increased TG synthesis and LD formation in order to allow the synthesis of PGE2 which provides a second signal for inflammatory activity.
A surprising finding from the current studies was that inflammatory macrophages have increased pools of long chain acylcarnitines. We reason that this reflects increased substrate levels due to increased FA uptake and synthesis, and subsequent acylcarnitine accumulation due to mitochondrial dysfunction with the cessation of FAO. The functional significance of acylcarnitine accumulation is unknown, but given that long chain acylcarnitines increased further when TG synthesis was inhibited, it may serve as an alternative pathway to LD development ( Fig. 1h ) for sequestering FA. Increased acylcarnitine accumulation following DGAT1 inhibition has been reported previously in other cell types 29, 30 . However, in MEFs, accumulated acylcarnitines due to DGAT1 inhibition were reported to themselves cause mitochondrial dysfunction 29 . Export of long chain acylcarnitines from mitochondria and from cells has been reported 31 , raising the possibility that accumulated acylcarnitines may be released to serve specific extracellular functions, including roles in sterile inflammation 32 associated with macrophage activation. The dissociation of increased Cpt1a expression from FAO is important, since Cpt1a/Cpt-dependent FAO generally works to counteract LD development in macrophages 33 , and enforced expression of a permanently active Cpt1a mutant in a macrophage cell line (RAW) increased FAO and subsequently prevented LD development and inhibited cytokine production in response to an inflammatory signal 34 .
Altered mitochondrial function, in which FAO and OXPHOS are inhibited and the TCA cycle is fragmented to support the use of citrate and aconitate for fatty acid and itaconate production respectively, are core metabolic features of inflammatory macrophage activation 3, 6, 7, 35, 36 . These events, alongside increased FA uptake and increased DGAT expression, create an environment in which TG synthesis is promoted. The finding that LDs, which store TGs, play an important role in maximizing inflammatory macrophage function raises the possibility that LD development is a major objective of metabolic rewiring in these cells. In this scenario, coordinated increases in LD development and Ptges1 and Ptges2 expression enable the framework for enhanced PGE2 synthesis, which provides a strong positive feedback signal for the production of pro-IL-1b 28 . IL-1b is considered the gatekeeper of inflammation in both infectious and sterile settings, since it is able to broadly induce the production of other proinflammatory mediators such as TNF, GM-CSF, G-CSF, IL-6, IL-8, NO, as well PGE2 and additional IL-1b 37 . While events that we have shown here to be linked to each other through LDs, such as IL-1b and PGE2 production, have been linked to protective mechanisms in microbial infections 38, 39 , there are also clear examples in which exacerbated production of these mediators is linked to the development of severe diseases such as cancer, neurodegenerative diseases, atherosclerotic disease and rheumatologic disorders [40] [41] [42] [43] . Our findings raise the possibility of targeting TG synthesis for therapeutic purposes in these settings.
dislocation, and bone marrow, blood and peritoneal lavage were harvested post mortem. For in vivo studies, mice were injected i.p. with 8 mg kg -1 LPS (Sigma), and body temperature was monitored for the duration of the experiment using an infrared thermometer (Bioseb).
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